Cancer Cytology
Reporting Procedures and Interpretation
The Cancer Cytology Unit uses The Bethesda System (TBS) for reporting Pap results. Negative results are reported upon completion of quality control procedures. Abnormal results must be confirmed and signed by a pathologist (CLIA 88 regulation). The Cancer Cytology Unit contracts for pathology services thus requiring additional turn around time for pathologist review and courier service.
A computer-generated report (not the DHHS form #1010 submitted with the Pap test) is returned to the health department. A laboratory generated follow-up DHHS form #1011 for the collection of follow-up data is sent with all Pap smear results of HPV, dysplasia or more severe findings or second consecutive ASCUS (Atypical Squamous Cells of Undetermined Significance). Case follow-up/disposition is essential to determine program effectiveness, as a part of laboratory quality assurance and to meet CLIA '88 requirements.
Any slide can be read immediately upon request
Sometimes a backlog of slides results in delayed reporting of results. The Cytology Unit now maintains contracts for Pap screening services to prevent a backlog of slides. Recommendations on interpretation of Pap test results, patient treatment and follow-up can be found in the DHHS document, Cervical Screening Manual: A Guide for Health Departments and Providers. A computer generated report (not the DHHS 1010 submitted with the Pap test) is returned to the health department. A laboratory generated Follow-up Form (DHHS 1011) for the collection of follow-up data is sent with all Pap test results of HPV, dysplasia or more severe findings and second consecutive cellular atypia (ASCUS).
Recommendations on the interpretation of Pap test results, patient treatment and follow-up can be found in the DHHS document, Cervical Screening Manual: A Guide for Health Departments and Providers.
Records
DHHS #1010 forms are retained for two years. Results are recorded electronically and kept indefinitely. Slides are kept for five years. Physicians should be advised that the slides are available for review when patients are referred for follow-up.
